New view on treatment of sexually transmitted diseases with azithromycin;Novi pogled na primjenu azitromicina u liječenju spolno prenosivih infekcija

Medicus

Volumn 13, Issue 2, 2004, Pages 247-253

  Škerk, Višnja ^a   Krhen, Ivan ^b   Francetić, Igor ^b   Baršić, Bruno ^a   Vrčić, Hrvoje ^b  

^a Croatia   (Croatia)

^b KBC Zagreb   (Croatia)

Author keywords

Antimicrobial treatment; Azithromycin; Sexually transmitted diseases

Indexed keywords

AZITHROMYCIN; BETA LACTAM ANTIBIOTIC; CEFTRIAXONE; CIPROFLOXACIN; ERYTHROMYCIN; METRONIDAZOLE; PENICILLIN G;

ANTIMICROBIAL THERAPY; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CLINICAL FEATURE; DOSE RESPONSE; DRUG INDICATION; HUMAN; MEDICAL LITERATURE; MEDICAL RESEARCH; PROSTATITIS; REACTIVE ARTHRITIS; REVIEW; SEXUALLY TRANSMITTED DISEASE; SYPHILIS; UTERINE CERVICITIS;

EID: 33645226452     PISSN: 1330013X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (44)

1. PLIVA d.d. Sumamed®. azitromicin. Monografija. Zagreb 1994
2. FRANCETIĆ I. Azitromicin - 10 godina od prve registracije - ponos i predrasude. Pharmaca 1999;37:149-58.
3. BRYSKIER A, BUTZLER JP. Macrolides. U: Finch RG, Greenwood D, Norrby SR, Whitley RJ. (ur.) Antibiotic and chemotherapy. Edinburg Churchill Livingstone 2003:310-25.
4. World Health Organization. Guidelines for the management of sexually transmitted infection. Geneva: WHO;2003.
5. Spolno prenosive bolesti. The Merck Manual of diagnostic and therapy. 17. izd. Split: Placebo, 2000:1433-53.
6. LIPOZENČIĆ J. ur. Spolno prenosive bolesti i infekcije. Zagreb: Medicinska naklada 2003.
7. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines. MMWR 2002;51 (RR-6)
8. Center for Disease Control and Prevention. 1998 guidelines for treatment of sexually transmitted diseases. MMWR 1998;47 (RR-1):49-59.
9. Služba za epidemiologiju zaraznih bolesti. Hrvatski zavod zajavno zdravstvo
10. Referentni centar Ministarstva zdravstva i socijalne skrbi za dijagnostikusifilisa i lajmske bolesti. Postupnik za dijagnostiku i terapiju sifilisa. Zagreb, 2004.
11. California STD treatment guidelines for adults and adolescents 2004. WWW.stdhivtraining.org
12. STAMM WE, HICKS CB, MARTIN DH i sur. Azithromycin for empirical treatment of the nongonococcal urethritis syndrome in men: A randomized double-blind study. JAMA 1995;274:545-9.
13. MARTIN DH, MROZKOWSKI TF, DALU ZA i sur. A controlled trial of a single dose of azithromycin for the treatment of chlamydial urethritis and cervicitis. N Engl J Med, 1992;327:921-5.
14. SCHOENWALD S, ŠKERK V, VINCE A, STRUGAR J. Kliničko ispitivanje djelotvornosti i podnošljivosti azitromicina u bolesnika s klamidijskim cervicitisom/ uretritisom. Pharmaca 1997;36:59-66.
15. STAMM WE, JONES RB, BATTEIGER BE. Chlamydia trachomatis (trachoma, perinatal infections, lymphogranuloma venereum, and other genital infections). U: Mandell GL, Bennett JE, Dolin R. (ur.) Mandell, Douglas, and Bennett's Principles and practice of infectious diseases. USA: Elsevier, Churchill Livingstone, 2005:2239-55.
16. GOMBERG M. Perzistentna klamidijska infekcija, Medicus. 2003;12:179-88.
17. SCHACHLER J. Chlamydia. U: Gorbach SL, Barlett JG, Blacklow NR. (ur.) Infectious diseases. Philadelphia: Lippincott Williams Wilkins; 2004:1865-74.
18. HILLIS SD, COLES B, LITCHFILD B i sur. Doxycycline and azithromycin for prevention of chlamydial persistence or recurrence one month after treatment in women: A useeffectiveness study in public health settings. Sex Transm Dis 1998;25:5-11.
19. FORTENBERRY JD, BRIZENDINE EJ, KATZ BP i sur. Subsequent STDs among adolescent women with C. trachomatis, N. gonorrhoeae or T. vaginalis. SexTransm Dis 1999;26:26-32.
20. STAMM WE, GEISLER WM, SUCHLAND RJ. Assessment of antimicrobial resistance in C. trachomatis strains associated with treatment failure or some strain recurrence. U: Schachler J, Christiansen G, Clarke IN i sur. (ur.) Chlamydial infections, proceedings of the tenth international Chlamydial symposium, San Francisco; 2002.
21. ŠKERK V, SCHOENWALD S, BARŠIĆ B i sur. Chlamydia trachomatis in urogenital infections. Pharmaca 1999;37:75-86.
22. ŠKERK V, SCHOENWALD S, STRAPAČ Z i sur. Duration of clinical symptoms in female patients with acute urethral syndrome caused by Chlamydia trachomatis treated with azithromycin or doxycycline. J Chemother 2001;13:176-81.
23. ŠKERK V, SCHOENWALD S, STRAPAČ Z i sur. Duration of clinical symptoms in female patients with acute urethral syndrome caused by Ureaplasma urealyticum treated with azithromycin or doxycycline. J Chemother 2000;12:533-5.
24. ŠKERK V, SCHOENWALD S, GRANIĆ J i sur. Chronic prostatitis caused by Trichomonas vaginalis- diagnosis and treatment. J. Chemother 2004;14:537-8.
25. VRČIĆ H. Zdjelična upalna bolest. Medicus 2003;12:189-92.
26. RAULSTON JE. Pharmacokinetics of azithromycin and erythromycin in human endometrial epithelial cells and in cells infected with Chlamydia trachomatis. J Antimicrob Chemother 1994;34:765-76.
27. PAUL TR, KNIGHT ST, RAULSTON JE, WYRICK PB. Delivery of azithromycin to Chlamydia trachomatis - infected polarized human endometrial epithelial cells by polymorphonuclear leucocytes. J Antimicrob Chemother 1997;39:623-30.
28. AMSDEN GW, NAFZIGER AN, FOULDS G. Pharmacokinetics in serum and leuko yte exposures of oral azithromycin, 1,500 mg miligrams, given over 3- or 5-day period in healthy subject;. Antimicrob Agents Chemother 1999;43:163-5.
29. Uputa o uporabi lijeka
30. BEVAN CD, RIDGWAY GL, ROTHERMEL CD. Efficacy and safety of azithromycin as monotherapy or combined with metronidazole compared with two standard multidrug regimens for the treatment of acute pelvic inflammatory disease. J International Medical Research 2003;31:45-54
31. ŠKERK V, PUNTARIĆ A, BEGOVAC J i sur. Komparativno ispitivanje djelotvornosti i podnošljivosti intravenoznog azitromicina i intravenoznog i oralnog azitromicina u liječenju upalne bolesti male zdjelice uzrokovane klamidijom trahomatis. Infektol Glasn 2003;23:125-8.
32. Mr. sc. DENI KARELOVIĆ, dr. med., specialist ginekologije i opstetricije. Klinika za ženske bolesti i porode, Klinička bolnica Split, usmeno priopćenje.
33. NABER KG, WEIDNER W. Prostatitis, epididymitis and orchitis. U: Cohen J, Powderly WG. (ur.) Infection diseases. Edinburg: Mosby, 2004:745-50.
34. ŠKERK V, KRHEN I, SCHOENWALD S i sur. The role of unusual pathogens in prostatitis syndrome. Int J Antimicrob Agents 2004;245:53-56
35. ŠKERK V, SCHOENWALD S, KRHEN I i sur. Comparativeanalysis of azithromycin and ciprofloxacin in the treatment of chronic prostatitis caused by Chlamydia trachomatis. Int J Antimicrob Agents 2003;21:457-62.
36. ŠKERK V, KRHEN I, LISIĆ M i sur. Comparative randomized pilot study of azithromycin and doxycycline eficacy and tolerability in the treatment of prostate infection caused by Chlamydia trachomatis. Int J Antimicrob Agents 2004;24:188-91.
37. ŠKERK V, KRHEN I, LISIĆ M. i sur. Azithromycin: 4,5- or 6,0-gram dose in the treatment of patients with chronic prostatitis caused by Chlamydia trachomatis - a randomized study. J Chemother 2004;16:408-10
38. ŠKERK V, SCHOENWALD S, KRHEN I i sur. Azithromycin in the treatment of chronic prostatitis caused by Chlamydia trachomatis. J Chemother 2001;13:664-5.
39. ŠKERK V, MAREKOVIĆ I, MARKOVINOVIĆ L i sur. Comparative randomized pilot study of azithromycin and doxycycline efficacy and tolerability in the treatment prostatae infection caused by Ureaplasma urealyticum. Chemotherapy 2005. - u tisku
40. GERARD HC, BRANIGAN PJ, SCHUMACHER HR JR, HUDSON AP. Synovial Chlamydia trachomatis in patients with reactive arthritis/Reiter's syndrome are viable but show aberant gene expression. J Rheumatol 1998;25:734-42.
41. LAUHIO A, LEIRISALO-REPO M, LÄHDEVIRTA J i sur. Double-blind, placebo-controlled study of three-month treatment with lymecycline in reactive arthritis, with special reference to Chlamydia arthritis. Arthritis Rheum 1991;34:6-14.
42. WALLENHAUPT J, HAMMER M, POTT HG, ZEIDLER H. A double-blind placebo controlled comparison of 2 weeks versus 4 months treatment with doxycycline in chlamydia-induced arthritis. Arthritis Rheum 1997;40: S 143.
43. BARDIN T, ENEL C, CORNELIS F i sur. Antibiotic treatment of venereal disease and Reiter's syndrome in a Greenland population. Arthritis Rheum. 1992;35:190-4.
44. KVIEN TK, GASTON JSH, BARDIN T i sur. Three month treatment of reactive arthritis with azithromycin: a EULAR double blind, placebo controlled study. Ann Rheum Dis 2004;63:1113-9.